Conclusion: The current systematic review and dose-response meta-analysis of RCTs revealed a beneficial effect in both stress and anxiety following Ashwagandha supplementation. However, further high-quality studies are needed to firmly establish the clinical efficacy of the plant.
PubMed 36017529 ↗Ashwagandha
Also known as Withania Somnifera, KSM-66, Sensoril
The short answer. People are split on Ashwagandha — 44% of 1,321 say it helped. It is most often used for anxiety: 88% of 881 reports say that improved. It is well studied — 48 meta-analyses on PubMed. The most common complaint is anhedonia.
From 2,447 mentions in total — the rest didn't say how it went and aren't counted.
What Ashwagandha does, according to users
Of the people who reported each effect, the share who said it got better.
2 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 48 meta-analyses on PubMed ↗ · 59 randomized trials ↗
Conclusion: The findings from the included studies indicate that Ashwagandha formulations have beneficial effects on stress and anxiety. The adverse effects associated with Ashwagandha are limited; however, further information is required to determine its safety with long-term administration.
PubMed 39348746 ↗Conclusion: Caffeine enhances attention and executive functions. Together, the results from the compiled studies highlight the nootropic effects and the inconsistencies regarding PDNs that require further research.Supplemental data for this article is available online at https://doi.org/10.1080/10408398.2021.2021137.
PubMed 34978226 ↗Conclusion: Ashwagandha extract appears to has a beneficial effect in improving sleep in adults. However, data on the serious adverse effects of Ashwagandha extract are limited, and more safety data would be needed to assess whether it would be safe for long-term use.
PubMed 34559859 ↗85 human trials on ClinicalTrials.gov test Ashwagandha — 51 completed, 12 recruiting now. See all on ClinicalTrials.gov ↗
- Dose-Response Effects of Short-Term Ashwagandha on Anaerobic Exercise and Cognitive Function in Resistance-Trained Athletes · Resistance Exercise Performance, Cognitive Functions · 2025
- Withania Somnifera for Moderate-to-Severe Persistent Asthma · Asthma · 2026
- A Clinical Trial to Evaluate the Effects of a Dietary Supplement on Digestive Health, Energy, and Skin Health · Digestive Health, Skin Health · 2025
Reports to the FDA
Adverse-event reports about supplements containing it, submitted to the US FDA by consumers and doctors.
135 reports name a product containing Ashwagandha (2009–2026); 56 involved hospitalization or worse. Most often reported:
- Diarrhoea · 32
- Nausea · 22
- Vomiting · 20
- Pruritus · 16
- Rash · 11
- Malaise · 10
A report doesn't prove the supplement caused the problem — many products contain several ingredients, and these counts can't tell you how often it happens. Source: FDA CAERS ↗ · raw reports (openFDA) ↗.
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
6 recalls of products named for Ashwagandha. Most recent:
- 2026-06-17 · Class III: Dry tea blends product containing Ashwagandha root which is an unsafe food additive. record ↗
- 2022-01-19 · Class I: During an FDA investigation the firm was notified that the product contains undeclared milk. record ↗
- 2016-05-11 · Class III: Pursuant to a consent decree for injunctive relief the recalling firm was ordered to recall all products because they are misbranded, unapproved new drugs… record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
LiverTox rates Ashwagandha B — a highly likely cause of liver injury (12–50 published cases). LiverTox entry ↗
“Ashwagandha may be safe when taken in the short term (up to 3 months). There is not enough information to allow conclusions about its long-term safety to be reached.” NCCIH ↗
- Traditionally used in Ayurveda as Rasayana (rejuvenative tonic).
- Traditionally used in Ayurveda to relieve general debility, especially during convalescence or old age.
- Traditionally used in Ayurveda to help relieve restlessness and/or nervousness (which helps (to) promote sleep).
- Traditionally used in Ayurveda to balance aggravated Vata (nervine).
Required cautions: Ask a health care practitioner if symptoms persist or worsen. Ask a health care practitioner before use if you are pregnant or breastfeeding. When using this product exercise caution if you drive or use machinery as you may experience drowsiness.
The EMA reviewed Winter-cherry root and did not issue a monograph (public statement). EMA ↗
NIH has funded 3 research projects with Ashwagandha in the title, $682,928 in total (2015–2024). NIH RePORTER ↗
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“I paired it with maca and ashwaganda and it legit felt like a steroid cycle.”
“I sleep better. I'm more relaxed. Stress is lower... it caused me terrible depression that lifted once I stopped.”
“My five year old daughter fell beside me and I didn't feel empathy towards her. I stopped taking that shit.”
“Completely believe this. It's literally impossible for me to feel panic/anxiety when I'm fully on Ashwagandha. It's a good life.”
Ashwagandha compared
Other options for anxiety
Sources
- User reports: 2,447 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA recalls ↗
- LiverTox (NIH) ↗
- NCCIH (NIH) ↗
- NIH RePORTER ↗
- Health Canada ↗
- European Medicines Agency ↗
- US Food and Drug Administration: CAERS adverse-event reports ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate